What are Qiming Venture Partners's red flags?

Weak or unreproducible science. No clear regulatory pathway. Small addressable patient population. No clinical advisory board. Overpromising timelines.

What sectors does Qiming Venture Partners invest in?

Qiming Venture Partners focuses on AI, Bio, Healthtech.

What is the typical check size for Qiming Venture Partners?

Qiming Venture Partners typically writes checks between $2000000M and $50000000M.

AI simulation

How to Pitch Qiming Venture Partners

Q: How do I pitch Qiming Venture Partners?

To pitch Qiming Venture Partners, practice against our AI simulation built from their investment thesis: Asia's leading healthcare investor. Deep expertise in biotech, medical devices, and digital health across China and Asia. Looks for scientific rigour, regulatory pathway clarity, and large unmet medical needs. You have 30 minutes to answer real questions like Walk me through the clinical evidence. and What is your regulatory pathway and timeline?. Get a 12-dimension scored verdict.

A practical guide based on our AI simulation of Qiming Venture Partners's investment thesis — distilled from public memos, interviews, and track record. Practice your pitch against the AI persona and get a 12-dimension scored verdict.

AI-generated from public data. Not official Qiming Venture Partners content.

Investment Thesis

Asia's leading healthcare investor. Deep expertise in biotech, medical devices, and digital health across China and Asia. Looks for scientific rigour, regulatory pathway clarity, and large unmet medical needs.

What They Look For

Sectors

AIBioHealthtech

Stages

SERIES_ASERIES_B_PLUS

Typical check size: $2000000M – $50000000M

Red Flags

Things Qiming Venture Partners investors watch for — avoid these in your pitch.

Weak or unreproducible science
No clear regulatory pathway
Small addressable patient population
No clinical advisory board
Overpromising timelines

Questions They'll Ask

Prepare answers for these. The AI persona will challenge you on them.

Walk me through the clinical evidence.
What is your regulatory pathway and timeline?
What is the addressable patient population, and how did you size it?
Who is on your scientific advisory board?
What is the hardest regulatory hurdle you face?

1 AI Persona to Pitch

Nisa Leung

Managing Partner

Deeply knowledgeable, scientifically trained, methodical. Judges by evidence and regulatory reality, not narrative. · Scientifically rigorous, data-driven, patient but thorough. Asks the questions a medical reviewer would ask.

Pitch Nisa

Ready to pitch?

Pitch the AI simulation of Qiming Venture Partners's thesis. Get a 12-dimension scored verdict. If you pass, your report surfaces to the real fund.

See Qiming Venture Partners personas

2 free pitches to start · 1 free every day